ResearcherA2 Biotherapeutics Inc.Active in the last 2 years
Eric W Ng
Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.
Their work
- Papers
- 0
- Trials
- 3
- Grants
- 0
- Collaborators
- 0
2021: 1 trial · 2022: none · 2023: 1 trial · 2024: none · 2025: 1 trial
Trials 3
- A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products Study director NCT06885424↗
- A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression Study director NCT05736731↗
- Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing Study director NCT04981119↗
Closest collaborators
No collaborators recorded.
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.